Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile.

Querfeld C, Leung S, Myskowski PL, Curran SA, Goldman DA, Heller G, Wu X, Kil SH, Sharma S, Finn KJ, Horwitz S, Moskowitz A, Mehrara B, Rosen ST, Halpern AC, Young JW.

Cancer Immunol Res. 2018 Jun 12. pii: canimm.0270.2017. doi: 10.1158/2326-6066.CIR-17-0270. [Epub ahead of print]

PMID:
29895574
2.

Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit.

Pastores SM, Goldman DA, Shaz DJ, Kostelecky N, Daley RJ, Peterson TJ, Tan KS, Halpern NA.

Cancer. 2018 May 4. doi: 10.1002/cncr.31409. [Epub ahead of print]

PMID:
29727916
3.

Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.

van Beek EJAH, Hernandez JM, Goldman DA, Davis JL, McLaughlin K, Ripley RT, Kim TS, Tang LH, Hechtman JF, Zheng J, Capanu M, Schultz N, Hyman DM, Ladanyi M, Berger MF, Solit DB, Janjigian YY, Strong VE.

Ann Surg Oncol. 2018 Jul;25(7):2027-2033. doi: 10.1245/s10434-018-6502-x. Epub 2018 May 3.

PMID:
29725898
4.

A novel image-based system for risk stratification in patients with desmoplastic small round cell tumor.

Saltsman JA 3rd, Price AP, Goldman DA, Hammond WJ, Danzer E, Magnan H, Slotkin E, Tap WD, Heaton TE, Modak S, LaQuaglia MP.

J Pediatr Surg. 2018 Mar 6. pii: S0022-3468(18)30153-2. doi: 10.1016/j.jpedsurg.2018.02.068. [Epub ahead of print]

PMID:
29605262
5.

Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?

Aherne EA, Pak LM, Goldman DA, Gonen M, Jarnagin WR, Simpson AL, Do RK.

Abdom Radiol (NY). 2018 Feb 28. doi: 10.1007/s00261-018-1505-4. [Epub ahead of print]

PMID:
29492607
6.

The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.

Goldman DA, Hovinga K, Reiner AS, Esquenazi Y, Tabar V, Panageas KS.

J Neurosurg. 2018 Jan 5:1-9. doi: 10.3171/2017.6.JNS17393. [Epub ahead of print]

PMID:
29303449
7.

A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.

Kramer K, Pandit-Taskar N, Humm JL, Zanzonico PB, Haque S, Dunkel IJ, Wolden SL, Donzelli M, Goldman DA, Lewis JS, Lyashchenko SK, Khakoo Y, Carrasquillo JA, Souweidane MM, Greenfield JP, Lyden D, De Braganca KD, Gilheeney SW, Larson SM, Cheung NV.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26754. Epub 2017 Sep 22.

PMID:
28940863
8.

Endoscopic Ultrasound as a Pretreatment Clinical Staging Tool for Gastric Cancer: Association with Pathology and Outcome.

Merkow RP, Herrera G, Goldman DA, Gerdes H, Schattner MA, Markowitz AJ, Strong VE, Brennan MF, Coit DG.

Ann Surg Oncol. 2017 Nov;24(12):3658-3666. doi: 10.1245/s10434-017-6050-9. Epub 2017 Aug 16.

PMID:
28815443
9.

Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma.

Hernandez JM, Beylergil V, Goldman DA, van Beek E, Gonen M, Tang L, Downey R, Rizk N, Shah M, Strong V, Janjigian Y, Schöder H, Coit DG.

Ann Surg. 2018 May;267(5):898-904. doi: 10.1097/SLA.0000000000002306.

PMID:
28767564
10.

High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Nougaret S, Lakhman Y, Gönen M, Goldman DA, Miccò M, D'Anastasi M, Johnson SA, Juluru K, Arnold AG, Sosa RE, Soslow RA, Vargas HA, Hricak H, Kauff ND, Sala E.

Radiology. 2017 Nov;285(2):472-481. doi: 10.1148/radiol.2017161697. Epub 2017 Jun 16.

PMID:
28628421
11.

Impact of Palliative Medicine Involvement on End-of-Life Services for Patients With Cancer With In-Hospital Deaths.

Wiesenthal A, Goldman DA, Korenstein D.

J Oncol Pract. 2017 Sep;13(9):e749-e759. doi: 10.1200/JOP.2016.019356. Epub 2017 Jun 8.

PMID:
28594585
12.

Recurrence patterns following irreversible electroporation for hepatic malignancies.

Langan RC, Goldman DA, D'Angelica MI, DeMatteo RP, Allen PJ, Balachandran VP, Jarnagin WR, Kingham TP.

J Surg Oncol. 2017 May;115(6):704-710. doi: 10.1002/jso.24570. Epub 2017 May 11.

13.

Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies.

Creasy JM, Goldman DA, Gonen M, Dudeja V, Askan G, Basturk O, Balachandran VP, Allen PJ, DeMatteo RP, D'Angelica MI, Jarnagin WR, Peter Kingham T.

J Gastrointest Surg. 2017 Aug;21(8):1254-1261. doi: 10.1007/s11605-017-3436-8. Epub 2017 May 8.

PMID:
28484891
14.

18F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer.

Ulaner GA, Castillo R, Wills J, Gönen M, Goldman DA.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1420-1427. doi: 10.1007/s00259-017-3709-1. Epub 2017 Apr 29.

PMID:
28456837
15.

Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer.

Shukla-Dave A, Wassberg C, Pucar D, Schöder H, Goldman DA, Mazaheri Y, Reuter VE, Eastham J, Scardino PT, Hricak H.

World J Radiol. 2017 Mar 28;9(3):134-142. doi: 10.4329/wjr.v9.i3.134.

16.

Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes.

Creasy JM, Goldman DA, Dudeja V, Lowery MA, Cercek A, Balachandran VP, Allen PJ, DeMatteo RP, Kingham TP, D'Angelica MI, Jarnagin WR.

J Am Coll Surg. 2017 May;224(5):906-916. doi: 10.1016/j.jamcollsurg.2016.12.058. Epub 2017 Feb 13.

17.

Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.

Nicolau C, Sala E, Kumar A, Goldman DA, Schoder H, Hricak H, Vargas HA.

AJR Am J Roentgenol. 2017 Apr;208(4):849-853. doi: 10.2214/AJR.16.17133. Epub 2017 Jan 17.

18.

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.

Mantha S, Goldman DA, Devlin SM, Lee JW, Zannino D, Collins M, Douer D, Iland HJ, Litzow MR, Stein EM, Appelbaum FR, Larson RA, Stone R, Powell BL, Geyer S, Laumann K, Rowe JM, Erba H, Coutre S, Othus M, Park JH, Wiernik PH, Tallman MS.

Blood. 2017 Mar 30;129(13):1763-1767. doi: 10.1182/blood-2016-10-747170. Epub 2017 Jan 12.

19.

18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.

Wang Y, Ayres KL, Goldman DA, Dickler MN, Bardia A, Mayer IA, Winer E, Fredrickson J, Arteaga CL, Baselga J, Manning HC, Mahmood U, Ulaner GA.

Clin Cancer Res. 2017 Jun 15;23(12):3053-3060. doi: 10.1158/1078-0432.CCR-16-2197. Epub 2016 Dec 23.

20.

Abdominal wall endometriosis: differentiation from other masses using CT features.

Yarmish G, Sala E, Goldman DA, Lakhman Y, Soslow RA, Hricak H, Gardner GJ, Vargas HA.

Abdom Radiol (NY). 2017 May;42(5):1517-1523. doi: 10.1007/s00261-016-0998-y.

21.

Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.

Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, Nougaret S, Sosa RE, Vargas HA, Soslow RA, Abu-Rustum NR, Hricak H, Sala E.

Eur Radiol. 2017 Jul;27(7):2903-2915. doi: 10.1007/s00330-016-4623-9. Epub 2016 Dec 5.

PMID:
27921159
22.

Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers.

Ulaner GA, Goldman DA, Corben A, Lyashchenko SK, Gönen M, Lewis JS, Dickler M.

J Nucl Med. 2017 Jul;58(7):1037-1042. doi: 10.2967/jnumed.116.183335. Epub 2016 Nov 17.

PMID:
27856630
23.

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia.

Reiss SN, Buie LW, Adel N, Goldman DA, Devlin SM, Douer D.

Ann Hematol. 2016 Dec;95(12):2009-2015. Epub 2016 Aug 20.

24.

Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma.

Shoushtari AN, Bluth MJ, Goldman DA, Bitas C, Lefkowitz RA, Postow MA, Munhoz RR, Buchar G, Hester RH, Romero JA, Fitzpatrick LJ, Weiser MR, Panageas KS, Wolchok JD, Chapman PB, Carvajal RD.

Melanoma Res. 2017 Feb;27(1):57-64. doi: 10.1097/CMR.0000000000000306.

25.

Franklin Delano Roosevelt's (FDR's) (1882-1945) 1921 neurological disease revisited; the most likely diagnosis remains Guillain-Barré syndrome.

Goldman AS, Schmalstieg EJ, Dreyer CF, Schmalstieg FC Jr, Goldman DA.

J Med Biogr. 2016 Nov;24(4):452-459. Epub 2015 Oct 27.

PMID:
26508622
26.

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation.

Shah GL, Yahalom J, Matasar MJ, Verwys SL, Goldman DA, Bantilan KS, Zhang Z, McCall SJ, Moskowitz AJ, Moskowitz CH.

Br J Haematol. 2016 Nov;175(3):440-447. doi: 10.1111/bjh.14245. Epub 2016 Jul 5.

27.

Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis.

Vargas HA, Schor-Bardach R, Long N, Kirzner AN, Cunningham JD, Goldman DA, Moskowitz CS, Sosa RE, Sala E, Panicek DM, Hricak H.

Abdom Radiol (NY). 2017 Jan;42(1):271-277. doi: 10.1007/s00261-016-0851-3.

28.

Evaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance Imaging.

Lawrence EM, Warren AY, Priest AN, Barrett T, Goldman DA, Gill AB, Gnanapragasam VJ, Sala E, Gallagher FA.

PLoS One. 2016 Jul 28;11(7):e0159652. doi: 10.1371/journal.pone.0159652. eCollection 2016.

29.

Nanophotonic resonators for InP solar cells.

Goldman DA, Murray J, Munday JN.

Opt Express. 2016 May 16;24(10):A925-34. doi: 10.1364/OE.24.00A925.

PMID:
27409965
30.

Letter to the Editor: Biases in estimation of overall survival in patients who underwent repeat resection of glioblastoma.

Goldman DA, Panageas KS.

J Neurosurg. 2016 Aug;125(2):519-22. doi: 10.3171/2015.11.JNS152515. Epub 2016 Jun 3. No abstract available.

PMID:
27257842
31.

Trends in Critical Care Beds and Use Among Population Groups and Medicare and Medicaid Beneficiaries in the United States: 2000-2010.

Halpern NA, Goldman DA, Tan KS, Pastores SM.

Crit Care Med. 2016 Aug;44(8):1490-9. doi: 10.1097/CCM.0000000000001722.

32.

(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, Jochelson MS, Gönen M.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1937-44. doi: 10.1007/s00259-016-3402-9. Epub 2016 Apr 30.

33.

February consultation #8.

Goldman DA.

J Cataract Refract Surg. 2016 Feb;42(2):344. doi: 10.1016/j.jcrs.2016.01.009. No abstract available.

PMID:
27026469
34.

Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection.

Lim II, Goldman DA, Farber BA, Murphy JM, Abramson SJ, Basu E, Roberts S, LaQuaglia MP, Price AP.

J Pediatr Surg. 2016 Jun;51(6):975-80. doi: 10.1016/j.jpedsurg.2016.02.069. Epub 2016 Mar 2.

35.

Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.

Ulaner GA, Goldman DA, Gönen M, Pham H, Castillo R, Lyashchenko SK, Lewis JS, Dang C.

J Nucl Med. 2016 Sep;57(9):1350-6. doi: 10.2967/jnumed.115.170456. Epub 2016 Mar 3.

36.

Prostate MRSI predicts outcome in radical prostatectomy patients.

Zakian KL, Hatfield W, Aras O, Cao K, Yakar D, Goldman DA, Moskowitz CS, Shukla-Dave A, Tehrani YM, Fine S, Eastham J, Hricak H.

Magn Reson Imaging. 2016 Jun;34(5):674-81. doi: 10.1016/j.mri.2016.01.003. Epub 2016 Jan 26.

37.

Ratio of Tumor to Normal Prostate Tissue Apparent Diffusion Coefficient as a Method for Quantifying DWI of the Prostate.

Barrett T, Priest AN, Lawrence EM, Goldman DA, Warren AY, Gnanapragasam VJ, Sala E, Gallagher FA.

AJR Am J Roentgenol. 2015 Dec;205(6):W585-93. doi: 10.2214/AJR.15.14338.

PMID:
26587948
38.

Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.

Sala E, Micco M, Burger IA, Yakar D, Kollmeier MA, Goldman DA, Gonen M, Park KJ, Abu-Rustum NR, Hricak H, Vargas HA.

Int J Gynecol Cancer. 2015 Oct;25(8):1461-7. doi: 10.1097/IGC.0000000000000519.

39.

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.

Vargas HA, Hötker AM, Goldman DA, Moskowitz CS, Gondo T, Matsumoto K, Ehdaie B, Woo S, Fine SW, Reuter VE, Sala E, Hricak H.

Eur Radiol. 2016 Jun;26(6):1606-12. doi: 10.1007/s00330-015-4015-6. Epub 2015 Sep 22.

40.

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.

Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gönen M, Osborne JR, Jochelson M, Hudis C, Morrow M, Ulaner GA.

J Nucl Med. 2015 Nov;56(11):1674-80. doi: 10.2967/jnumed.115.161455. Epub 2015 Aug 20.

41.

Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery.

Sutton EJ, Watson EJ, Gibbons G, Goldman DA, Moskowitz CS, Jochelson MS, Dershaw DD, Morris EA.

Radiology. 2015 Nov;277(2):381-7. doi: 10.1148/radiol.2015142717. Epub 2015 Jun 18.

42.

Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer.

Burger IA, Goldman DA, Vargas HA, Kattan MW, Yu C, Kou L, Andikyan V, Chi DS, Hricak H, Sala E.

Gynecol Oncol. 2015 Sep;138(3):554-9. doi: 10.1016/j.ygyno.2015.06.010. Epub 2015 Jun 17.

43.

Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.

Ulaner GA, Goldman DA, Sauter CS, Migliacci J, Lilienstein J, Gönen M, Schöder H, Moskowitz CH, Zelenetz AD.

Radiology. 2015 Nov;277(2):518-26. doi: 10.1148/radiol.2015142556. Epub 2015 Jun 2.

44.

Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.

Dashevsky BZ, Goldman DA, Parsons M, Gönen M, Corben AD, Jochelson MS, Hudis CA, Morrow M, Ulaner GA.

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1666-1673. doi: 10.1007/s00259-015-3080-z. Epub 2015 May 14.

45.

Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.

Vargas HA, Burger IA, Goldman DA, Miccò M, Sosa RE, Weber W, Chi DS, Hricak H, Sala E.

Eur Radiol. 2015 Nov;25(11):3348-53. doi: 10.1007/s00330-015-3729-9. Epub 2015 Apr 28.

46.

Response.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H.

Radiology. 2015 Feb;274(2):625. No abstract available.

PMID:
25785291
47.

Comparison of prostate volume measured by endorectal coil MRI to prostate specimen volume and mass after radical prostatectomy.

Mazaheri Y, Goldman DA, Di Paolo PL, Akin O, Hricak H.

Acad Radiol. 2015 May;22(5):556-62. doi: 10.1016/j.acra.2015.01.003. Epub 2015 Feb 21.

PMID:
25708867
48.

Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.

Lakhman Y, Katz SS, Goldman DA, Yakar D, Vargas HA, Sosa RE, Miccò M, Soslow RA, Hricak H, Abu-Rustum NR, Sala E.

Ann Surg Oncol. 2016 Apr;23(4):1271-8. doi: 10.1245/s10434-015-4410-x. Epub 2015 Feb 10.

49.

Volume and landmark analysis: comparison of MRI measurements obtained with an endorectal coil and with a phased-array coil.

Mazaheri Y, Afaq AA, Jung SI, Goldman DA, Wang L, Aslan H, Zelefsky MJ, Akin O, Hricak H.

Clin Radiol. 2015 Apr;70(4):379-86. doi: 10.1016/j.crad.2014.12.002. Epub 2014 Dec 29.

PMID:
25554540
50.

Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.

Lakhman Y, Yakar D, Goldman DA, Katz SS, Vargas HA, Miccò M, Zheng J, Moskowitz CS, Soslow RA, Hricak H, Abu-Rustum NR, Sala E.

Abdom Imaging. 2015 Aug;40(6):1761-8. doi: 10.1007/s00261-014-0337-0.

Supplemental Content

Loading ...
Support Center